Hyaline Fibromatosis Syndrome: A Novel Mutation and Recurrent Founder Mutation in the CMG2/ANTXR2 Gene.

Authors

Leila Youssefian, Thomas Jefferson University; Tehran University of Medical SciencesFollow
Hassan Vahidnezhad, Thomas Jefferson University; Pasteur Institute of IranFollow
Yahya Aghighi, Tehran University of Medical Sciences
Vahid Ziaee, Tehran University of Medical SciencesFollow
Sirous Zeinali, Pasteur Institute of Iran; Kawsar Human Genetics Research Center
Maryam Abiri, Pasteur Institute of Iran; Tehran University of Medical Sciences
Jouni Uitto, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-4-2017

Comments

This article is the author’s final published version in Acta Dermato-Venereologica

Volume 97, Issue 1, January 2017, Pages 108-109.

The published version is available at DOI: 10.2340/00015555-2459. Copyright © Acta Dermato-Venereologica

Recommended Citation

Youssefian, Leila; Vahidnezhad, Hassan; Aghighi, Yahya; Ziaee, Vahid; Zeinali, Sirous; Abiri, Maryam; and Uitto, Jouni, "Hyaline Fibromatosis Syndrome: A Novel Mutation and Recurrent Founder Mutation in the CMG2/ANTXR2 Gene." (2017). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper 66.
https://jdc.jefferson.edu/dcbfp/66

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

PubMed ID

27174544